Deciphera Pharmaceuticals DCPH Stock
Deciphera Pharmaceuticals Price Chart
Deciphera Pharmaceuticals DCPH Financial and Trading Overview
| Deciphera Pharmaceuticals stock price | 15.05 USD |
| Previous Close | 14.18 USD |
| Open | 14.19 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 800 |
| Day's Range | 14 - 14.6 USD |
| 52 Week Range | 10.87 - 22.76 USD |
| Volume | 372.26K USD |
| Avg. Volume | 566.98K USD |
| Market Cap | 1.14B USD |
| Beta (5Y Monthly) | 0.668309 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.29 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.33 USD |
DCPH Valuation Measures
| Enterprise Value | 743.17M USD |
| Trailing P/E | N/A |
| Forward P/E | -7.127451 |
| PEG Ratio (5 yr expected) | -0.27 |
| Price/Sales (ttm) | 8.258095 |
| Price/Book (mrq) | 2.5936496 |
| Enterprise Value/Revenue | 5.375 |
| Enterprise Value/EBITDA | -3.989 |
Trading Information
Deciphera Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.668309 |
| 52-Week Change | 23.85% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 22.76 USD |
| 52 Week Low | 10.87 USD |
| 50-Day Moving Average | 14.25 USD |
| 200-Day Moving Average | 16.09 USD |
DCPH Share Statistics
| Avg. Volume (3 month) | 566.98K USD |
| Avg. Daily Volume (10-Days) | 468.29K USD |
| Shares Outstanding | 78.52M |
| Float | 41.02M |
| Short Ratio | 7.64 |
| % Held by Insiders | 29.98% |
| % Held by Institutions | 73.08% |
| Shares Short | 4.31M |
| Short % of Float | 7.38% |
| Short % of Shares Outstanding | 5.48% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -131.38% |
| Operating Margin (ttm) | -136.76% |
| Gross Margin | -47.58% |
| EBITDA Margin | -134.75% |
Management Effectiveness
| Return on Assets (ttm) | -25.29% |
| Return on Equity (ttm) | -51.049% |
Income Statement
| Revenue (ttm) | 138.26M USD |
| Revenue Per Share (ttm) | 1.7 USD |
| Quarterly Revenue Growth (yoy) | 14.39% |
| Gross Profit (ttm) | -62555000 USD |
| EBITDA | -186316000 USD |
| Net Income Avi to Common (ttm) | -181648000 USD |
| Diluted EPS (ttm) | -2.2 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 398.63M USD |
| Total Cash Per Share (mrq) | 5.08 USD |
| Total Debt (mrq) | 28.32M USD |
| Total Debt/Equity (mrq) | 6.44 USD |
| Current Ratio (mrq) | 5.674 |
| Book Value Per Share (mrq) | 5.606 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -150964992 USD |
| Levered Free Cash Flow (ttm) | -83792376 USD |
Profile of Deciphera Pharmaceuticals
| Country | United States |
| State | MA |
| City | Waltham |
| Address | 200 Smith Street |
| ZIP | 02451 |
| Phone | 781 209 6400 |
| Website | https://www.deciphera.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 300 |
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing medicines to improve the lives of cancer patients in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 in combination with RTK/RAS/MAP kinase signaling pathway inhibition to treat RAS/RAF mutant cancers. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.
Q&A For Deciphera Pharmaceuticals Stock
What is a current DCPH stock price?
Deciphera Pharmaceuticals DCPH stock price today per share is 15.05 USD.
How to purchase Deciphera Pharmaceuticals stock?
You can buy DCPH shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Deciphera Pharmaceuticals?
The stock symbol or ticker of Deciphera Pharmaceuticals is DCPH.
Which industry does the Deciphera Pharmaceuticals company belong to?
The Deciphera Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Deciphera Pharmaceuticals have in circulation?
The max supply of Deciphera Pharmaceuticals shares is 80.8M.
What is Deciphera Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Deciphera Pharmaceuticals PE Ratio is now.
What was Deciphera Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Deciphera Pharmaceuticals EPS is -2.29 USD over the trailing 12 months.
Which sector does the Deciphera Pharmaceuticals company belong to?
The Deciphera Pharmaceuticals sector is Healthcare.
Deciphera Pharmaceuticals DCPH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2060.1 USD — |
-1.99
|
— — | 2051.95 USD — | 2093.4 USD — | — - | — — |
| Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG | 2541.54 USD — |
-1.89
|
— — | 2531.95 USD — | 2572.66 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}